514
Participants
Start Date
January 13, 2017
Primary Completion Date
October 11, 2019
Study Completion Date
July 1, 2024
Atezolizumab
Will be administered as per the schedule described in individual arm.
Atezolizumab Placebo
Will be administered as per the schedule described in individual arm.
Cobimetinib
Will be administered as per the schedule described in individual arm.
Vemurafenib
Will be administered as per the schedule described in individual arm.
Vemurafenib Placebo
Will be administered as per the schedule described in individual arm.
Medizinische Universität Wien, Vienna
Orszagos Onkologiai Intezet, Budapest
Cliniques Universitaires St-Luc, Brussels
Sint Augustinus Wilrijk, Wilrijk
Peter Maccallum Cancer Centre, Melbourne
UZ Leuven Gasthuisberg, Leuven
Tauranga Hospital, Clinical Trials Unit, Tauranga
CHU Sart-Tilman, Liège
Princess Alexandra Hospital, Woolloongabba
Mid Central DHB, Palmerston North
Royal Adelaide Hospital, Adelaide
LKH Innsbruck, Innsbruck
Wellington Hospital, Newtown, Wellington
Fiona Stanley Hospital, Murdoch
University of Szeged Szent-Györgyi Albert Clinical Center, Szeged
Medical University of Graz, Department of Dermatology, Graz
Fondazione Del Piemonte Per L'oncologia Ircc Di Candiolo, Candiolo
Charite - Universitätsmedizin Berlin, Berlin
Sharett Institute - Hadassah Hebrew University Medical Center, Jerusalem
IRCCS Istituto Nazionale Per La Ricerca Sul Cancro (IST), Genoa
St. Luke's University Health network, Bethlehem
Irccs Istituto Nazionale Dei Tumori (Int), Milan
Irccs Istituto Europeo Di Oncologia (IEO), Milan
Elbekliniken Buxtehude, Buxtehude
UKSH Universitatsklinikum Schleswig-Holstein, Lübeck
UKSH Kiel, Kiel
Hospital Ramon y Cajal, Madrid
Hospital Universitario La Paz, Madrid
Medizinische Hochschule Hannover, Hanover
Clinica Universitaria de Navarra, Pamplona
UF Health Cancer Center at Orlando Health, Orlando
Groupe Hospitalier Saint André - Hôpital Saint André, Bordeaux
A.O. Universitaria S. Maria Della Misericordia Di Udine, Udine
Mount Sinai Medical Center, Miami Beach
Centre Eugene Marquis, Rennes
Universitätsmedizin Göttingen, Göttingen
Centre Hospitalier Universitaire de Grenoble - Albert Michallon, Grenoble
Hospital Universitario Virgen de la Macarena, Seville
CHU de Nantes, Nantes
Universitatsklinikum Essen, Essen
Hospital General Universitario de Valencia, Valencia
IRST Istituto Scientifico Romagnolo Per Lo Studio E Cura Dei Tumori, Sede Meldola, Meldola
Fachklinik Hornheide, Münster
Hospital Universitario Miguel Servet, Zaragoza
Klinikum d.Universität zu Köln Klinik u.Poliklinik f.Dermatologie, Cologne
Hopital Robert Debre, Reims
A.O.U. Senese Policlinico Santa Maria Alle Scotte, Siena
Universitatsklinikum Mainz, Mainz
Hopital Claude Huriez - CHU Lille, Lille
Universitatsklinik Heidelberg, Heidelberg
Istituto Tumori ?Giovanni Paolo II?, Oncologia, Bari
Zentrum für Dermatoonkologie, Universitäts-Hautklinik Tübingen, Tübingen
Highlands Oncology Group, Springdale
CHU de Rouen - Hôpital Charles Nicolle, Rouen
IRCCS Istituto Nazionale Tumori Fondazione Pascale, Napoli
Klinikum der Ludwigs-Maximilians-Universität München, München
Arizona Oncology Associates, PC - HAL, Tempe
UC Irvine Medical Center, Orange
Universitätsklinikum Regensburg, Regensburg
Universitätsklinikum Würzburg, Würzburg
HELIOS Klinikum Erfurt, Erfurt
"FSBSI Russian Oncological Scientific Center n.a. N.N. Blokhin", Moscow
Moscow City Oncology Hospital #62, Moscovskaya Oblast
Rambam Health Care Campus, Haifa
Rabin MC, Petah Tikva
Ella Institute - Sheba Medical Center, Ramat Gan
University of Alabama at Birmingham, Birmingham
Hospital das Clinicas - UFRGS, Porto Alegre
Centro de Pesquisa e Ensino em Oncologia de Santa Catarina - CEPEN, Florianópolis
Instituto do Cancer do Estado de Sao Paulo - ICESP, São Paulo
Clinicas Oncologicas Integradas - COI, Rio de Janeiro
Beneficencia Portuguesa de Sao Paulo, São Paulo
Arthur J.E. Child Comprehensive Cancer Center-Calgary, Calgary
Cancer Care Manitoba, Winnipeg
Juravinski Cancer Clinic, Hamilton
LHSC - Victoria Hospital, London
Lakeridge Health Oshawa, Oshawa
The Ottawa Hospital Cancer Centre, Ottawa
Princess Margaret Hospital, Toronto
CHU de Quebec - Hopital de l'Enfant-Jesus, Québec
Universitätsklinikum Leipzig, Leipzig
Harzklinikum Dorothea Christiane Erxleben GmbH, Standort Quedlinburg, Quedlinburg
Laiko General Hospital Athen, Athens
Metropolitan Hospital, Pireaus
IFO - Istituto Regina Elena, Rome
Erasmus Mc - Daniel Den Hoed Kliniek, Rotterdam
Uniwersyteckie Centrum Kliniczne, Gdansk
Narodowy Inst.Onkol.im.Sk?odowskiej-Curie Pa?stw.Inst.Badawczy Kraków, Krakow
COZL Oddzial Onkologii Klinicznej z pododdzialem Chemioterapii Dziennej, Lublin
Uniwersytecki Szpital Kliniczny w Poznaniu, Późna
Narodowy Instytut Onkologii im. Marii Sk?odowskiej-Curie - Pa?stwowy Instytut Badawczy, Warsaw
Dolno?l?skie Centrum Onkologii, Pulmonologii i Hematologii, Wroclaw
IPO de Lisboa, Lisbon
IPO do Porto, Porto
"FBI Scientific Research Institute of Oncology n. a. N. N. Petrov", Saint Petersburg
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Samsung Medical Center, Seoul
Hospital Universitari Vall d'Hebron, Barcelona
Hospital Clínic i Provincial, Barcelona
Fundacion Instituto Valenciano de Oncologia (IVO), Valencia
Bristol Haematology and Oncology centre, Bristol
Beatson West of Scotland Cancer Centre, Glasgow
Ipswich Hospital, Ipswich
St James Uni Hospital, Leeds
Guys and St Thomas NHS Foundation Trust, Guys Hospital, London
Freeman Hospital, New Castle Upon Tyne
Singleton Hospital, Swansea
Royal Cornwall Hospital, Truro
Hoffmann-La Roche
INDUSTRY